| Subject |
A U.S. patent titled “METHODS FOR PREPARATION OF PLECTRANTHUS AMBOINICUS EXTRACTS” has been granted. |
- Date of occurrence of the event:2023/12/05
- Company name:ONENESS BIOTECH CO., LTD.
- Relationship to the Company (please enter “head office” or “subsidiaries”):head office
- Reciprocal shareholding ratios:NA
- Cause of occurrence:The Company has been informed by the patent agency that a U.S. patent titled ” METHODS FOR PREPARATION OF PLECTRANTHUS AMBOINICUS EXTRACTS” has been granted under the patent number US 11,826,395 B2.
- Countermeasures:None
- Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):
This patent is to protect the manufacturing process of the functional ingredient in ON101, which is part of global patent protection of ON101 in drug and medical device application. No imitation of manufacturing the extract of Plectranthus amboinicus will be allowed.
|
